To quickly advance the internationalization of the business landscape, Sanyou launches new offices in The Shard London and CIC Rotterdam in May 2023, respectively, after the CIC Boston branch in the US.
Sanyou Biopharmaceuticals Co., Ltd. is a top national high-tech biotechnology company with its headquarters located in Shanghai, China. It specializes in the R&D and services of cutting-edge biological medications. Realizing the goal of “to make it easy to discover innovative biological drugs anywhere” and resolving the outstanding fundamental obstacles in the R&D and industrialization of these drugs are the company’s commitments. Sanyou currently boasts a state-of-the-art “super-trillion innovative-drug lead molecule library” and a top-tier core technology platform for integrated R&D and preclinical development of novel biological therapeutics. Based on the three leading novel drug R&D technology platforms in the industry—”super-trillion, integration, and intelligence”—Sanyou is a fierce competitor in offering one-stop services for preclinical integrated R&D processes.
By the end of 2022, Sanyou had assembled a group of over 300 creative biopharmaceutical R&D specialists and constructed a state-of-the-art drug R&D facility spanning over 20,000 square meters, ranking among the best in the world. Through its “4C” business services—differentiated CRO, integrated CDO, collaborative CPO, and distinctive CRS—the company has made inroads into the industry. Around 600 pharmaceutical businesses, drug R&D centers, and companies that manufacture diagnostic reagents and products have formed business ties with Sanyou globally. China, the US, Europe, and other parts of the world are all included in its business network.
One of London’s most well-known landmarks is The Shard. Situated in the center of London’s transportation network, this hub serves as a meeting point for firms with top-notch office space. Sanyou intends to leverage The Shard’s superior connectivity to stay in constant communication with its global clientele and provide its superior services.
Situated in Rotterdam, the country’s second-biggest city, the Dutch CIC is a division of the Cambridge Innovation Center (CIC) in the Netherlands. Known as the “Gateway to Europe,” Rotterdam is a significant port that links Europe, North America, Asia, Africa, and Australia. Sanyou will be able to better leverage the local and surrounding resources as a result of its residence in CIC Rotterdam, offering its international clientele more convenient and superior biopharmaceutical-related services.
With dozens of highly skilled professionals in its international product and marketing team, an expansive global business network, a robust new drug R&D platform, and an all-inclusive business service system, Sanyou will make the most of its marketing networks in China, the US, and Europe, continue to push the boundaries of the global business landscape, and advance to become a cutting-edge drug R&D service provider globally influential!
